Digital Pathology Devices Can Now Be Used Remotely Under Emergency FDA Guidance
Executive Summary
The immediately-in-effect guidance document says devices to review digital pathology slides can be modified so they can be used outside a laboratory or health care setting, and allows remote digital pathology devices that have not been 510(k)-cleared to be marketed while the US fights the COVID-19 pandemic.